Phospholipids for the Treatment of Asthma

摘要

There is disclosed the use of naturally occurring surface active phospholipids (SAPLs, eg. dipalmitoylphosphatidylcholine and phosphatidyl glycerol), preferably as a commercially available mixture ALEC (RTM) for the treatment of asthma by inhalation. A suitable dispersion device for the powdered medicament (figs. 2 and 3) comprises a casing (10) containing a propellant canister (4) and a drug vial (15). A valve arrangement (16) operated by depression of the inverted end (18) of the canister allows the introduction of propellant by a tube (19,21) into the vial. A second tube (22,24) provides exit means from the vial to the site of application.